Skip to main content
Article thumbnail
Location of Repository

Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm

By Bernd Muehling, Alexander Oberhuber, Hubert Schelzig, Gisela Bischoff, Nikolaus Marx, Ludger Sunder-Plassmann and Karl H Orend
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2663432
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2004). A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.
    2. (2006). Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol,
    3. (2007). Aortic aneurysms secrete interleukin-6 into the circulation.
    4. (2005). Association of osteoprotegerin with human abdominal aortic aneurysm progression.
    5. (2002). Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms.
    6. (2008). Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms.
    7. (2000). Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
    8. (1997). Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
    9. (1999). Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms.
    10. (2007). Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts. Prog Cardiovasc Dis,
    11. (2002). Proteolysis of the abdominal aortic aneurysm wall and the association with rupture.
    12. (2004). Serum profi les of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
    13. (2007). Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
    14. (2006). Simvastatin suppresses experimental aortic aneurysm expansion.
    15. (2007). Statin therapy is associated with improved outcomes in vascular surgery patients with renal impairment.
    16. (2006). Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.
    17. (2006). The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Ann Vasc Surg,
    18. (2006). The impact of early administration of low-dose atorvastatin treatment on infl ammatory process, in patients with unstable angina and low cholesterol level.
    19. (2000). The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.